The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - AstraZeneca; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Pfizer; Roche
Travel, Accommodations, Expenses - AstraZeneca; Pfizer; Roche
 
Consulting or Advisory Role - AstraZeneca; PharmaMar; Roche
Speakers' Bureau - AstraZeneca; Pharmamar; Roche
Travel, Accommodations, Expenses - AstraZeneca; PharmaMar; Roche
PAOLA-1: An ENGOT/GCIG phase III trial of olaparib versus placebo combined with bevacizumab as maintenance treatment in patients with advanced ovarian cancer following first-line platinum-based chemotherapy plus bevacizumab.
 
Isabelle Laure Ray-Coquard
Honoraria - AstraZeneca; PharmaMar; Roche
Consulting or Advisory Role - Abbvie; Amgen; Pfizer
 
Philipp Harter
No Relationships to Disclose
 
Antonio Gonzalez Martin
No Relationships to Disclose
 
Claire Cropet
No Relationships to Disclose
 
Sandro Pignata
Honoraria - AstraZeneca; pharmamar; Roche
Consulting or Advisory Role - AstraZeneca; Pfizer; PharmaMar; Roche; tesaro
Research Funding - MSD (Inst); Pfizer (Inst); Roche
 
Keiichi Fujiwara
Honoraria - Asahi Kasei; Chugai Pharma; Daiichi Sankyo; Eisai; Janssen Oncology; Kyowa Hakko Kirin; Lilly Japan; Nippon Kayaku; Novartis; Ono Pharmaceutical; Taiho Pharmaceutical; Yakult Honsha; Zeria Pharmaceutical
Consulting or Advisory Role - AstraZeneca; Chugai Pharma; Eisai; MSD; Pfizer; Taiho Pharmaceutical
Research Funding - AstraZeneca (Inst); Chugai Pharma (Inst); Eisai (Inst); GlaxoSmithKline (Inst); Immunogen (Inst); Kaken Pharmaceutical (Inst); Lilly (Inst); MSD (Inst); Oncotherapeutics (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Shionogi (Inst); Taiho Pharmaceutical (Inst); Zeria Pharmaceutical (Inst)
 
Christian Marth
No Relationships to Disclose
 
Ignace Vergote
Consulting or Advisory Role - AstraZeneca
 
Mansoor Raza Mirza
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Tesaro
 
Nicoletta Colombo
Employment - Ignyta (I)
Consulting or Advisory Role - Amgen; AstraZeneca; Clovis Oncology; MSD Oncology; Pfizer; PharmaMar; Roche/Genentech
 
Per Rosenberg
No Relationships to Disclose
 
Johanna Unelma Maenpaa
Honoraria - AstraZeneca; Roche; SOBI
Consulting or Advisory Role - AstraZeneca; Roche
 
Eric Pujade Lauraine
Consulting or Advisory Role - AstraZeneca; Pfizer; Roche
Speakers' Bureau - AstraZeneca; Pfizer; Roche
Travel, Accommodations, Expenses - AstraZeneca; Roche